← All Guides

How to Pitch a Healthtech Startup

Healthcare investors evaluate startups through a unique lens: clinical evidence, regulatory timelines, and reimbursement pathways matter as much as product-market fit. The best healthtech pitches show you understand that building the technology is only half the battle — getting it adopted by providers, payers, and patients is the other half.

Digital health funding has corrected from its 2021 peak, but investors remain active in areas with clear clinical evidence and reimbursement pathways. AI-assisted diagnostics, remote monitoring, and workflow automation are seeing the most traction. Investors are wary of "wellness" plays and prefer products that integrate into clinical workflows with measurable outcomes.

What Investors Look For

  • A clear FDA or regulatory pathway with realistic timelines — 510(k) vs. De Novo vs. PMA
  • Clinical evidence or a credible plan to generate it — pilot data from health systems is gold
  • Reimbursement strategy: who pays, what CPT codes apply, and what is the reimbursement per use
  • Distribution through existing clinical workflows rather than requiring behavior change
  • Understanding of HIPAA, SOC 2 Type II, and healthcare data security requirements
  • A clinical advisory board with practicing physicians who will champion adoption

Common Mistakes

  • Building a product that requires doctors to change their workflow — adoption will stall
  • Assuming clinical efficacy alone will drive sales — hospital procurement is a 12-18 month cycle
  • Skipping the reimbursement question — if insurers will not pay, hospitals will not buy
  • Underestimating the FDA timeline and treating it as a formality
  • Pitching a consumer health app without a clear path to clinical-grade validation

Key Metrics to Highlight

  • Clinical outcomes improvement (quantified — e.g., 23% reduction in readmissions)
  • Pilot-to-contract conversion rate at health systems
  • Average contract value and implementation timeline
  • Net revenue retention from existing health system clients
  • Cost savings per patient or per episode of care

Sample Investor Questions

  1. What is your regulatory pathway and expected timeline to clearance?
  2. Walk me through how a patient or provider actually uses this in their existing workflow.
  3. What clinical evidence do you have, and what studies are planned?
  4. Who is the buyer in a health system — the CIO, CMO, or department head? What is their budget cycle?
  5. What CPT or DRG codes does this map to, and what is the expected reimbursement?
  6. How do you handle patient data privacy and what certifications do you hold?

FAQ

Can I pitch before getting FDA clearance?

Yes — most healthtech startups raise pre-clearance. But you need a clear regulatory strategy, ideally with a regulatory consultant or former FDA reviewer on your team. Show investors your predicate devices (for 510(k)), your clinical data plan, and realistic timeline. Pre-submission meetings with the FDA are a strong signal.

How do I validate demand without a finished product?

Letters of intent from health systems are the gold standard. Even better: paid pilot agreements. Start by working with 2-3 clinical champions at target health systems who will co-develop and validate the product. Their testimonials and data carry enormous weight with investors.

Is B2B or B2C better for healthtech?

B2B (selling to health systems, insurers, or employers) is generally more investable because the reimbursement and procurement pathways are clearer. B2C health apps face high acquisition costs and low willingness to pay. The exception is chronic condition management where patients are highly motivated and insurers will subsidize the cost.

Ready to practice your healthtech pitch with an AI investor partner?

Apply Now